Behind Sinovac, Russia's Sputnik V vaccine is the next furthest ahead in the process.
In January 2021, approved the vaccine for emergency use and began a vaccination campaign on 2 February.
But right now, the volume and distribution of vaccines is insufficient to end the pandemic without the sustained and tailored application of public health measures that we know work.
S The Janssen vaccine leverages the AdVac vaccine platform to engineer a common cold virus to carry genetic instructions into the arm cells where they construct a replica of the coronavirus spike, triggering the immune system.
In March, received a donation of 400,000 doses from China and began vaccinations on 27 March.
On May 7, 2021, the announced the vaccine's approval.